Information Library
Results for: Regulatory & Quality
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Turkey Oncology Capabilities
Brochure — February 6, 2012
Turkey has outstanding access to patients with a population of almost 75 million. Quintiles recent experience demonstrates Turkey provides rapid patient enrollment with high patient retention rates and remains an emerging market with few competing studies – becoming a major hub for patient recruitment. -
Middle East Oncology capabilities
Brochure — February 6, 2012
Outstanding access to patients in the Middle East region with a population of over 200 million means this is an important emerging region for the biopharmaceutical industry and Quintiles has a proven track record of rapid patient enrollment with high patient retention rates. -
Sustainable Compliance Begins with a Strong Foundation
Brochure — December 8, 2011
The urgency of a problem often entices people to quickly focus on finding a solution and repairing the problem in order to immediately remedy the situation. -
Leveraging Compliance for Sustainable Business Advantage
Hear from the Experts — November 16, 2011
Article from Update Magazine, a publication of FDLI. “Leveraging Compliance for Sustainable Business Advantage” by Robert A. Rhoades, VP, Quality & Compliance Consulting -
Quintiles Addresses Key Considerations for Successful Biosimilar Development
Press Release — September 29, 2011 – Regulatory and commercial considerations are the primary drivers for successful biosimilar development, according to a new report from Quintiles.
-
Quintiles Helps Biopharma Companies Turn Compliance into a Business Advantage
Press Release — June 29, 2011 – Elevating compliance to achieve a strategic advantage allows biopharmaceutical companies to respond more rapidly to ever-changing conditions in the New Health, according to a new report from Consulting at Quintiles.
-
CDRH's Proposed Changes to the Premarket Notification [510k]
Hear from the Experts — May 27, 2011
On January 19, 2011, the FDA unveiled a plan to improve the 510(k) program, involving 25 actions the agency intends to implement during 2011, including new guidance and enhanced staf training. -
Quintiles Names Rick Sax New Head of Integrated Clinical Services
Press Release — May 23, 2011 – Quintiles announced the appointment of Frederic “Rick” Sax as Senior Vice President and Global Head of its Integrated Clinical Services division.rograms.
-
The Art of Compliance
White Paper — April 21, 2011
The Art of Compliance is more than just meeting regulatory requirements for a new drug, biologic or medical device. It is the ability to elevate compliance beyond execution to achieve strategic advantage. Its insight-based solutions facilitate quick and appropriate response to repidly changing conditions. -
Podcast: Process Driven Compliance
Hear from the Experts — March 31, 2011
Bob Rhoades, Practice Leader for Quality Systems with Consulting at Quintiles, explains the need for a process-driven approach to regulatory compliance.
